0000899140-24-001385.txt : 20241226 0000899140-24-001385.hdr.sgml : 20241226 20241226162803 ACCESSION NUMBER: 0000899140-24-001385 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20241223 FILED AS OF DATE: 20241226 DATE AS OF CHANGE: 20241226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUVRETTA CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001569064 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 241581353 BUSINESS ADDRESS: STREET 1: 540 MADISON AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127025204 MAIL ADDRESS: STREET 1: 540 MADISON AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cowen Aaron CENTRAL INDEX KEY: 0001869640 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 241581350 MAIL ADDRESS: STREET 1: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Averill Madison Master Fund, Ltd. CENTRAL INDEX KEY: 0002021243 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 241581352 BUSINESS ADDRESS: STREET 1: C/O SUVRETTA CAPITAL MANAGEMENT, LLC STREET 2: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-702-5205 MAIL ADDRESS: STREET 1: C/O SUVRETTA CAPITAL MANAGEMENT, LLC STREET 2: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Averill Master Fund, Ltd. CENTRAL INDEX KEY: 0001939329 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 241581351 BUSINESS ADDRESS: STREET 1: C/O SUVRETTA CAPITAL MANAGEMENT, LLC STREET 2: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-702-5205 MAIL ADDRESS: STREET 1: C/O SUVRETTA CAPITAL MANAGEMENT, LLC STREET 2: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Benitec Biopharma Inc. CENTRAL INDEX KEY: 0001808898 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 780-0819 MAIL ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 4 1 form4.xml X0508 4 2024-12-23 0001808898 Benitec Biopharma Inc. BNTC 0001569064 SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 true true 0002021243 Averill Madison Master Fund, Ltd. C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 true true 0001939329 Averill Master Fund, Ltd. C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 true true 0001869640 Cowen Aaron C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 true false Common stock, par value $0.0001 per share 2024-12-23 4 P 0 24360 10.98 A 7981725 I See footnotes Common stock, par value $0.0001 per share 2024-12-23 4 P 0 3142 10.98 A 958266 I See footnotes Common stock, par value $0.0001 per share 2024-12-24 4 P 0 17730 11.25 A 7999455 I See footnotes Common stock, par value $0.0001 per share 2024-12-24 4 P 0 2288 11.25 A 960554 I See footnotes Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature Suvretta Capital Management, LLC; By: /s/Andrew Nathanson , General Counsel & Chief Compliance Officer 2024-12-26 EX-99.1 2 s81635443a.htm EXPLANATION OF RESPONSES
Exhibit 99.1

Explanation of Responses:

(1)
This Form 4 is filed on behalf of Averill Master Fund, Ltd., a Cayman Islands exempted company (“Averill Master Fund”), Averill Madison Master Fund, Ltd., a Cayman Islands exempted company (“Averill Madison Master Fund” and, together with the Averill Master Fund, the “Funds”), Suvretta Capital Management, LLC, a Delaware limited liability company (“Suvretta Capital”), and Aaron Cowen (“Mr. Cowen”) (collectively, the “Reporting Persons”).  Suvretta Capital is the investment manager of the Funds.  Mr. Cowen may be deemed to control Suvretta Capital and therefore may be deemed to beneficially own shares of Common Stock (as defined below) held by the Funds.  Mr. Cowen disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of any indirect pecuniary interest therein.  The securities reported herein are directly held by either Averill Master Fund or Averill Madison Master Fund as noted herein. Each of the Funds may be deemed a director by deputization by virtue of Kishan Mehta, a portfolio manager of Suvretta Capital, serving on the board of directors of the Issuer.
(2)
The price reported in column 4 is a weighted average price.  These shares of common stock, par value $0.0001 per share (the “Common Stock”), of Benitec Biopharma Inc. (the “Issuer”) were purchased by Averill Master Fund in multiple open market transactions at prices ranging from $10.44 to $11.00 per share.  The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
(3)
The price reported in column 4 is a weighted average price.  These shares of Common Stock were purchased by Averill Madison Master Fund in multiple open market transactions at prices ranging from 10.44 to $11.00 per share.  The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
 (4)
The price reported in column 4 is a weighted average price.  These shares of Common Stock were purchased by Averill Master Fund in multiple open market transactions at prices ranging from $11.25 to $11.50 per share.  The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
 (5)
The price reported in column 4 is a weighted average price.  These shares of Common Stock were purchased by Averill Madison Master Fund in multiple open market transactions at prices ranging from $11.25 to $11.50 per share.  The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
EX-99.2 3 s81635443b.htm JOINT FILER INFORMATION
Exhibit 99.2

Joint Filer Information

Joint Filers:

1. Name:
Aaron Cowen
  
Address:
  
c/o Suvretta Capital Management, LLC
   
540 Madison Avenue, 7th Floor
   
New York, NY 10022
     
2. Name:
Averill Master Fund, Ltd.
  
Address:
  
c/o Suvretta Capital Management, LLC
   
540 Madison Avenue, 7th Floor
   
New York, NY 10022
     
3. Name:
Averill Madison Master Fund, Ltd.
  
Address:
  
c/o Suvretta Capital Management, LLC
   
540 Madison Avenue, 7th Floor
   
New York, NY 10022

EX-99.3 4 s81635443c.htm JOINT FILERS' SIGNATURES
Exhibit 99.3

Joint Filers’ Signatures




AVERILL MASTER FUND, LTD.


By:     /s/ Andrew Nathanson                                             
Date: December 26, 2024
 
Name:  Andrew Nathanson
  
 
Title:  Authorized Signatory
  
   
   
AVERILL MADISON MASTER FUND, LTD.
  
   
   
By:    /s/Andrew Nathanson                                               
Date:  December 26, 2024
 
Name:  Andrew Nathanson
  
 
Title:  Authorized Signatory
  
   
   
By:    /s/  Aaron Cowen                                                       
Date:  December 26, 2024
 
Name:  Aaron Cowen